18-F-FLT-PET for response evaluation of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with solid tumors.
SourceWorld Journal of Nuclear Medicine, 2012, 11, (2012), pp. 65-67
Article / Letter to editor
Display more detailsDisplay less details
World Journal of Nuclear Medicine
SubjectNCMLS 2: Immune Regulation ONCOL 3: Translational research; ONCOL 2: Age-related aspects of cancer; ONCOL 2: Age-related aspects of cancer NCEBP 4: Quality of hospital and integrated care; ONCOL 3: Translational research N4i 1: Pathogenesis and modulation of inflammation; ONCOL 5: Aetiology, screening and detection
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.